Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-04-25 to 2023-04-26
Current total value of award: $8364.6
Description: 4560712297!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML